merck

Opinion by Richard Sternberg COVID: Good News/Bad News Six weeks ago, I wrote about a new drug called malnupiravir from Merck that was a game changer in the treatment of COVID-19. When taken in the first few days of infection it was 50% effective in the prevention of hospitalization and death. While not as good as monoclonal antibodies this was considered an amazing result and the study was terminated early in order to immediately ask for emergency approval. It was…